Maine is currently facing a public health crisis due to an outbreak of HIV in Bangor. Syringe service programs are an important element in ending the HIV epidemic, and GLAD Law is working in Maine to increase access to these programs and ensure best practices are met.

LD219 “An Act to Limit Hypodermic Apparatus Exchange Programs to a One-for-one Exchange”

Actualizar: Victory! On April 17, 2025, LD219 died in committee.

Ley GLAD submitted testimony in opposition to LD219, a bill that would worsen public health outcomes by creating a one-for-one limit for syringe exchange programs. One-for-one needle exchange programs limit syringe distribution by requiring participants to return a needle before they are given a new one. These programs have been found to be less effective at reducing the number of people reusing syringes.

GLAD Law’s testimony advocates for comprehensive harm reduction strategies, including community clean-up efforts, safe disposal programs, and education initiatives, to address concerns around syringe litter while remaining responsive to public health needs.

LD1078 “An Act to Support Maine’s Public Health Objectives by Increasing Access to Hypodermic Apparatus Exchange Programs”

GLAD Law joined the Frannie Peabody Center in submitting testimony in support of LD1078, legislation that would increase access to life-saving care through syringe service programs. LD1078 would allow providers of syringe service programs to operate at multiple locations within a county under one license. This flexibility would increase access to care, enhance staff capacity, and increase the accessibility of safe disposal sites.